United Therapeutics | UTHR - Debt



United Therapeutics reported $200M in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
Amarin USD 0 0 Mar/2025
Ardelyx USD 206.64M 55.79M Jun/2025
Baxter International USD 10.31B 2.82B Mar/2025
Bayer EUR 39.39B 1.31B Mar/2025
Biogen USD 6.59B 296.8M Jun/2025
BioMarin Pharmaceutical USD 603.87M 8.22M Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Insmed USD 564.1M 567.29M Jun/2025
Ionis Pharmaceuticals USD 1.42B 169.27M Jun/2025
J&J USD 52.25B 15.62B Mar/2025
Moderna USD 741M 4M Jun/2025
Pfizer USD 60.93B 1.18B Jun/2025
PTC Therapeutics USD 286.01M 2.12B Jun/2025
Regeneron Pharmaceuticals USD 2.71B 300K Jun/2025
Sarepta Therapeutics USD 1.35B 215.59M Jun/2025
Teva Pharmaceutical Industries USD 17.52B 872M Jun/2025
United Therapeutics USD 200M 100M Mar/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025